BYROW replaces thousands of table formulas with one spill formula, making spreadsheets leaner and much more robust.

Century Therapeutics (IPSC) aims at a durable “once-and-done” Type 1 diabetes cure with hypoimmune iPSC beta cells; runway to 2029—click here to read now.

The round includes $270M in equity and $200M in EXIM-backed financing to support CesiumAstro's growth and new Texas facility.

The UPBEAT (c) clinical trial is a multicenter, open-label Phase 1/2 clinical trial designed to evaluate the safety, tolerability, pharmacodynamics, and preliminary efficacy of AFTX-201 in adults with ...

TrumpRX, a newly launched prescription discount program, is being promoted as a way for consumers to save money on medications at participating pharmacies ...

The Steam Machine is back from the dead. Not as a Valve-supported program for manufacturers to create living room PCs, but ...

Machine learning is helping neuroscientists organize vast quantities of cells’ genetic data in the latest neurobiological cartography effort.

Senate vote on disapproval resolution threatens tax season and child tax credit. Civil disobedience and advocacy for D.C.

With a clutch of key data and planned regulatory applications this year from Avidity Biosciences, REGENXBIO and Capricor ...

As safety-critical industries move beyond experimentation and toward production-grade adoption of Rust, 2026 marks a pivotal transition from promise to practical assurance.

Designed to be flight-cased or deployed in live event racks, Shogun AV-19 is capable of simultaneous recording of up to four ...

Gartner, Inc. (NYSE:IT) Q4 2025 Earnings Call Transcript February 3, 2026 Gartner, Inc. beats earnings expectations. Reported EPS is $3.94, expectations were $3.5. Operator: Good morning, everyone.